pimozide has been researched along with Pituitary Neoplasms in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, Q; Li, Z; Liang, J; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K | 1 |
| Canonico, PL; MacLeod, RM; Valdenegro, CA | 1 |
| Lamberts, SW; MacLeod, RM | 1 |
| Groshong, JC; Malarkey, WB; Milo, GE | 1 |
| Biagi, BA; Day, RN; Enyeart, JJ; Maurer, RA; Sheu, SS | 1 |
| Lehmeyer, JE; MacLeod, RM | 1 |
6 other study(ies) available for pimozide and Pituitary Neoplasms
| Article | Year |
|---|---|
Pimozide augments bromocriptine lethality in prolactinoma cells and in a xenograft model via the STAT5/cyclin D1 and STAT5/Bcl‑xL signaling pathways.
Topics: Animals; bcl-X Protein; Bromocriptine; Cell Line, Tumor; Cyclin D1; Humans; Mice; Mice, Nude; Pimozide; Pituitary Neoplasms; Prolactinoma; Rats; Signal Transduction; STAT5 Transcription Factor; Xenograft Model Antitumor Assays | 2021 |
The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
Topics: Animals; Bromocriptine; Dopamine; Female; Haloperidol; Male; Phosphates; Phosphatidylinositols; Pimozide; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactin; Rats; Rats, Inbred Strains; Sex Factors | 1983 |
Effects of cyproheptadine on prolactin synthesis and release by normal and suppressed pituitary glands and by dispersed pituitary tumor cells.
Topics: Animals; Cyproheptadine; Female; Haloperidol; Male; Methysergide; Perphenazine; Pimozide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats | 1978 |
Defective dopaminergic regulation of prolactin secretion in a rat pituitary tumour cell line.
Topics: Apomorphine; Cell Line; Dopamine; Dose-Response Relationship, Drug; Neoplasms, Experimental; Pimozide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Receptors, Dopamine | 1977 |
Blockade of low and high threshold Ca2+ channels by diphenylbutylpiperidine antipsychotics linked to inhibition of prolactin gene expression.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channels; Cell Line; Fluspirilene; Gene Expression; Kinetics; Luciferases; Membrane Potentials; Penfluridol; Pimozide; Piperidines; Pituitary Neoplasms; Prolactin; Recombinant Fusion Proteins; Spiro Compounds; Thyrotropin-Releasing Hormone | 1990 |
Restoration of prolactin synthesis and release by the administration of monoaminergic blocking agents to pituitary tumor-bearing rats.
Topics: Animals; Dopamine; Dopamine Antagonists; Female; Haloperidol; In Vitro Techniques; Leucine; Male; Neoplasms, Experimental; Perphenazine; Pimozide; Pituitary Gland; Pituitary Neoplasms; Prolactin; Rats; Tritium | 1974 |